Retirement Stock List
If you are in retirement, you should seek investments that are safe, generate income and still have the potential for growth. Dividends are taxed at a rate of 15%, which is lower than work-generated income. I cannot recommend to any retiree whether or not to purchase individual stocks. Every persons situation is different. I suggest being conservative and cautious first. Below is a list of possible stock securities that could offer generous income as well as potential growth. Please do your own research, as there are no gaurantees in the stock market. ======================================================================================================== 1. Company: Pfizer Inc. (PFE) Pfizer, Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals in the United States, Europe, Canada, Asia, and Latin America. Its Pharmaceutical segment offers products for cardiovascular and metabolic diseases, such as Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; and Exubera, the inhaled human insulin therapy for glycemic control. Its products for central nervous system disorders include Zoloft for various disorders; Geodon/Zeldox, a psychotropic agent; Aricept for Alzheimer's disease; and Lyrica for adjuctive therapy for adults with partial onsent epileptic seizures. This segment also offers Celebrex for osteoarthritis, adult rheumatoid arthritis, acute pain, menstrual pain, and familial adenomatous polyposis; Zithromax for bacterial infections; Vfend for serious and potentially fatal fungal infections, esophageal candidiasis, and blood stream infections in non-neutropenic patients; Zyvox for bacterial infections; and Viagra for erectile dysfunction; and Detrol for overactive bladder. In addition, it offers Camptosar, a therapy for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; Genotropin for various growth disorders; and Zyrtec for allergies and hives. The company's Animal Health segment offers parasiticides, anti-inflammatories, vaccines, and antibiotics. Pfizer also offers Celsentri (maraviroc), an oral CCR5, for HIV treatment. It serves retailers, clinics, pharmacies, doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. Pfizer has collaboration with Icagen, Inc.; Bristol-Myers Squibb Company; and Graffinity Pharmaceuticals AG. The company was founded in 1849 and is headquartered in New York, New York. Current Dividend Yield: 5.70% 52 WeeK Range: $21 - $27 ======================================================================================================== 2. Company: Altria Group Inc. (MO) Altria Group, Inc., through its subsidiaries, engages in the manufactures and sale of cigarettes and other tobacco products in the United States and internationally. The company sells its tobacco products to wholesalers, large retail organizations that include chain stores, and the armed services, as well as distributors, wholesalers, retailers, and state-owned enterprises. It also engages in the manufacture and sale of packaged foods and beverages, including canned meats, tomato, fruit juice, snacks, cheese and dairy, grocery, and convenient meals. The company sells its products to supermarket chains, wholesalers, super centers, club stores, mass merchandisers, distributors, convenience stores, gasoline stations, drug stores, value stores, and other retail food outlets. It also offers direct finance leasing services, primarily in transportation, power generation, and manufacturing equipment and facilities. The company was founded in 1919 and is based in New York, New York. Current Dividend Yield: 4.10% 52 Week Range: $63 - $87 ======================================================================================================== 3. Company: Merck & Co. Inc. (MRK) Merck & Co., Inc. engages in the discovery, development, manufacture, and marketing of products for human and animal health. It offers Singulair for treating asthma, and relief of symptoms of allergic rhinitis; Cozaar/Hyzaar and Vasotec for the treatment of hypertension/heart failure; Fosamax and Fosamax Plus D for the treatment and prevention of osteoporosis; Zocor, an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, an urology product for the treatment of symptomatic benign prostate enlargement; Maxalt, an acute migraine product; and Propecia for the treatment of male pattern hair loss. The company offers Varivax to prevent chickenpox; M-M-R II, for the treatment of measles, mumps, and rubella; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; Gardasil for the prevention of cervical cancer and genital warts; Pneumovax for the prevention of pneumococcal diseases; RotaTeq for the protection against rotavirus gastroenteritis in infants and children; and Zostavax, a vaccine for the prevention of shingles. It markets its products directly or through joint ventures to drug wholesalers and retailers, hospitals, government agencies, and managed health care providers. Merck & Co. has agreements with Neuromed Pharmaceuticals, Ltd. to develop compounds for treating pain and other neurological disorders; NicOx S.A. to develop antihypertensive drugs; FoxHollow Technologies, Inc. for atherosclerotic plaque analysis; and Ariad Pharmaceuticals, Inc. to develop AP23573, a mTOR inhibitor. It has collaboration with Asuragen, Inc. to develop a biomarker and pharmacogenomic test for cancer clinical trials; Dynavax Technologies Corp. to develop HEPLISAV, an investigational hepatitis B vaccine; and GTX, Inc. to develop selective androgen receptor modulators. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey. Current Dividend Yield: 3.20% 52 Week Range: $42 - $61 ========================================================================================================
4. Company: Southern Copper Corp. (PCU) Southern Copper Corporation produces copper, molybdenum, zinc, and silver. It engages in mining, milling, and flotation of copper ore to produce copper concentrates and molybdenum concentrates; the smelting of copper concentrates to produce anode and blister copper; and the refining of blister/anode copper to produce copper cathodes. The company also engages in the mining and processing of gold and lead, as well as produces refined copper using SX/EW technology. It operates the Toquepala and Cuajone mines in the Andes Mountains, which is located approximately 984 kilometers southeast of the city of Lima, Peru; and a smelter and refinery west of the Toquepala and Cuajone mines in the coastal city of Ilo, Peru. Southern Copper Corporation has its mining, smelting, and refining operations in Peru and Mexico, as well as exploration operations in Chile. The company, formerly known as Southern Peru Copper Corporation, was founded in 1952 and is based in Phoenix, Arizona. Southern Copper Corporation is a subsidiary of Americas Mining Corporation. Current Dividend Yield: 5.60% 52 Week Range: $62 - $143 ======================================================================================================== 5. Fund: Fairholme (FAIRX) The investment seeks long-term growth of capital. The investment primarily invest in equity securities of public companies, including but not limited to common stocks, partnership interests, business trust shares, convertible securities, and rights and warrants to subscribe for the purchase of such equity securities without regard to market capitalization or other categorizations. It holds a focused portfolio of no more than 25 equity securities. It may invest in securities of non-U.S. companies. The fund is nondiversified. ======================================================================================================== 6. Kimberly-Clark Corp. (KMB) Kimberly-Clark Corporation engages in the manufacture and marketing of health and hygiene products worldwide. It operates in four segments: Personal Care, Consumer Tissue, K-C Professional & Other, and Health Care. The Personal Care segment manufactures and markets disposable diapers, training and youth pants, and swim pants; baby wipes; feminine and incontinence care products; and related products. The Consumer Tissue segment manufactures and markets facial and bathroom tissue, paper towels, napkins, and related products for household use. The K-C Professional & Other segment manufactures and markets facial and bathroom tissue, paper towels, napkins, wipers and various safety products for the away-from-home marketplace. The Health Care segment manufactures and markets health care products, such as surgical gowns, drapes, infection control products, sterilization wrap, disposable face masks and exam gloves, respiratory products, and other disposable medical products. Products for household use are sold directly, and through wholesalers, to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets. Products for away-from-home use are sold through distributors and directly to manufacturing, lodging, office building, food service, health care establishments, and public facilities. The company was founded in 1872 and is headquartered in Dallas, Texas. Current Dividend Yield: 3.30% 52 Week Range: $62 - $72 ======================================================================================================== 7. Fund: Nuveen Insured Municipal Opportunity Fund Inc. (NIO) Nuveen Insured Municipal Opportunity Fund, Inc. operates as a closed-end, diversified management investment company. It invests primarily in a diversified portfolio of municipal obligations issued by state and local government authorities, as well as the United States territories. The fund's investment portfolio primarily consists of investment in companies operating in various sectors, including transportation, healthcare, utilities, housing/multifamily, and water and sewer sectors, as well as tax obligation/limited, tax obligation/general, the United States guaranteed. Nuveen Asset Management serves as the investment adviser of the fund. Nuveen Insured Municipal Opportunity Fund was founded in 1991 and is based in Chicago, Illinois. ======================================================================================================== 8. Company: Consolidated Edison Symbol: ED Consolidated Edison, Inc., through its subsidiaries, provides electric, gas, and steam utility services in the United States. It offers electric and gas service in southeastern New York and in adjacent areas of northern New Jersey and eastern Pennsylvania. The company also provides gas service in Manhattan, the Bronx, and parts of Queens and Westchester. As of December 31, 2006, the company served approximately 43,000 customers. Consolidated Edison was founded in 1884 and is based in New York, New York.Key Statistics Current Dividend Yield: 5.3% 52 Week Range: $42 - $52 ======================================================================================================== Disclaimer: I am not a registered investment advisor. Everything on this website is my opinion and put her for the enjoyment of my readers. I do not recommend making financial decisions based upon my opinions. I advocate doing your own research and making an informed decision. All information put forth on this website was obtained freely via the internet, radio and television. I do not have any contracts or deals with any financial newsletter of any kind. Income generated from this site is done through advertisements. I will always let my reader know if I hold any position on a recommendation I make. ========================================================================================================
Return to Home Page
|